You just read:

Sun Pharma Presents Long-term Study Results that Show Significant Skin Clearance with ILUMYA® (tildrakizumab-asmn) Maintained Over Four Years in People with Moderate-to-Severe Plaque Psoriasis

News provided by

Sun Pharmaceutical Industries Ltd.

Oct 09, 2019, 14:20 ET